In addition, to increase the robustness of our analysis, we selected KLF9 as a second potential target as it was identified as downregulated by YAP in an independent study conducted in MCF-10A cells and previously suggested to have tumor-suppressive activities (4, 23, 24, 25). The gene discussed is KLF9; the disease is neoplasm.